Precancerous colorectal lesions, or dysplasia, in patients with inflammatory bowel disease (IBD) confer markedly different risks of future colorectal cancer depending on dysplasia grade, according to ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

A new Crohn's & Colitis Foundation–led survey of more than 1,500 people living with or at risk for inflammatory bowel disease (IBD) found that 93% would be interested in a test to predict their or ...

Boehringer Ingelheim has penned a 1.05 billion euro ($1.26 billion) biobucks deal for Simcere’s preclinical inflammatory bowel disease (IBD) bispecific antibody. The deal centers on SIM0709, which ...

Caldera Therapeutics has burst onto the scene with $112.5 million in combined series A cash the Massachusetts biotech will use to fund development of an inflammatory bowel disease (IBD) drug licensed ...

2025 largely saw more of the same in the independent broker/dealer space, except for one big thing most advisors didn’t see coming: Commonwealth Financial Network’s sale to LPL Financial. LPL closed ...

Women with inflammatory bowel disease (IBD) are 3 times more likely to forgo having children than people without the condition — it’s a trend driven by fear and confusion about what the disease would ...

Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the gastrointestinal disease: ulcerative colitis and Crohn’s disease. But one ...

Inflammatory bowel disease (IBD), which causes inflammation in the digestive tract, may complicate other health concerns as patients age. To address the specific challenges faced by older adults with ...

As IBD cases surge worldwide, scientists reveal how Western eating habits destabilise the gut–immune axis, and why tailored nutrition may be the key to stopping inflammation before it starts. Review: ...